CLTN.SW stock fell 6.95% pre-market to CHF50.90 on 07 Mar 2026 after the March earnings release, with volume at 14,271 versus a 50-day average of 5,054. The move put COLTENE Holding AG (CLTN.SW) on the list of top losers on the SIX exchange in Switzerland as investors parsed EPS and margin details. We see technical oversold signals and a valuation gap versus recent averages that merit short-term caution and setup possible entry points for patient buyers using CHF50 support as a reference point. Meyka AI provides this real-time market analysis and score to frame next steps.

CLTN.SW stock performance pre-market

CLTN.SW opened at CHF53.10 and traded between CHF50.40 and CHF53.70, ending the pre-market quote at CHF50.90, down CHF3.80 or -6.95% from the previous close of CHF54.70. Intraday volume of 14,271 is 2.82x the average, signalling active selling pressure.

The one-day price swing widened after the 06 Mar 2026 earnings release, and the stock sits closer to its year low of CHF42.60 than its year high of CHF71.70, underscoring heightened short-term volatility for CLTN.SW stock.

Earnings reaction and CLTN.SW stock financials

COLTENE reported results tied to the earnings announcement on 06 Mar 2026, with trailing EPS at CHF2.40 and a trailing PE of 21.21. The market reacted within 24 hours, compressing the share price and prompting the pre-market decline.

Key balance-sheet and cash metrics: market cap CHF304.15M, shares outstanding 5,975,391, cash per share CHF2.74, and operating cash flow per share CHF2.28. For company filings and investor details see the COLTENE investor site COLTENE investor site and SIX market data SIX exchange.

Valuation and ratios for CLTN.SW stock

Valuation pockets that matter: price-to-sales 1.26, price-to-book 3.38, EV/EBITDA 12.04, and free cash flow yield 3.15%. The dividend per share is CHF2.50, equal to a trailing yield near 4.91%, but payout ratio sits above 100% at 1.04, which flags sustainability questions.

Leverage and coverage look moderate: debt-to-equity 0.56 and interest coverage 7.62x, which support solvency but mean investors should watch capital return policy after the earnings print.

Technical signals and Meyka AI grade for CLTN.SW stock

Technicals show short-term weakness: RSI 31.05 (near oversold), MACD negative with histogram -0.56, and price below both the 50-day average CHF55.34 and 200-day average CHF54.49. Bollinger lower band sits at CHF52.38, so the pre-market price is trading beneath the lower band and may test the CHF50.00 support.

Meyka AI rates CLTN.SW with a score of 72.35 out of 100 (B+, BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational only and not personal financial advice.

Forecasts and price targets for CLTN.SW stock

Meyka AI’s forecast model projects a yearly level of CHF56.53, a quarterly target of CHF59.32, and a monthly level near CHF60.50. Compared with the current CHF50.90, the model implies a yearly upside of 11.07% and a monthly upside of 18.82%. Forecasts are model-based projections and not guarantees.

Analyst-style price targets we monitor: conservative CHF48.00, base CHF56.00, and bullish CHF65.00, each tied to margin recovery and stable order trends in the dental instruments sector.

Risks and opportunities for CLTN.SW stock

Risks: a long cash conversion cycle (inventory days 177.27) and a payout ratio above 1.00 increase capital return risk if cash flow softens. The stock trades at a premium to some healthcare peers on PE and PB multiples, which may magnify downside on negative news.

Opportunities: strong ROE 14.37%, recent net income growth 71% year-over-year, and a defensive product mix in dental disposables support mid-term stability. Sector performance for healthcare shows muted weakness today, which can amplify company-specific moves.

Final Thoughts

CLTN.SW stock showed a clear pre-market sell-off to CHF50.90 on 07 Mar 2026, driven by the immediate market reaction to the March earnings release and heavier-than-normal volume of 14,271. Technical indicators are near oversold, with RSI 31.05 and price below the 50- and 200-day averages, which suggests short-term downside risk toward the CHF50.00 support. Valuation metrics mix defensive cash flow and a high payout ratio, leaving dividend sustainability an open question. Meyka AI’s forecast model projects a yearly level of CHF56.53, implying ~11.07% upside versus the current price; the monthly model at CHF60.50 implies near-term upside of ~18.82%. These projections are model-based and not guarantees. Investors should watch follow-up guidance, free cash flow execution, and inventory trends before increasing exposure. For active traders, a layered approach around CHF50.00–CHF55.00 can manage risk while monitoring operational updates.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.